Skip to main content

Table 2 Results of serum total carnitine levels and free carnitine levels between the ME/CFS/SEID patient group and the healthy control group

From: Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis

 

Total carnitine levels, ÎĽmol/L (SD)

Free carnitine levels, ÎĽmol/L (SD)

Study

ME/CFS/SEID patient group

Healthy control group

P-valuea

ME/CFS/SEID patient group

Healthy control group

P-valuea

Kuratsune H, et al. [12]

No data

No data

 

51.8 (9.5)

56.2 (9.7)

NS

Kuratsune H, et al. [13]

No data

No data

 

M 53.5 (8.5), F 46.8 (8.2)

No data

NS

Plioplys AV, et al. [14]

M 49.9 (9.1), F 41.2 (9.5)

M 59.3 (11.9), F 51.5 (11.6)

p < 0.05

M 40.6 (8.9), F 32.1 (6.9)

M 46.8 (10.0), F 40.1 (9.5)

p < 0.05

Kuratsune H, et al. [15]b

No data

No data

 

34.8 (7.8)

38.5 (8.1)

p < 0.05

Kuratsune H, et al. [15]c

No data

No data

 

No data

M 56.1 (10.7), F 43.6 (10.0)

 

Soetekouw PM, et al. [16]

46.9 (7.6)

48.9 (8.2)

NS

35.4 (7.6)

36.8 (6.5)

NS

Jones MG, et al. [17]

40.5 (8.7)

43.1 (9.8)

NS

33.2 (7.9)

36.6 (9.5)

NS

Reuter SE, et al. [18]

58.8 (13.6)

59.5 (12.9)

NS

45.0 (11.3)

45.2 (9.79)

NS

  1. aIn each study, those for which a p-value was not calculated are shaded
  2. bThe data in Swedish [15]
  3. cThe data in Japanese [15]
  4. ME myalgic encephalomyelitis, CFS chronic fatigue syndrome, SEID systemic exertion intolerance disease, SD standard deviation, M male, F female, NS not significant